Pfeiffenberger Brent
Century Therapeutics, Inc. · President and CEO
Pfeiffenberger Brent is listed in filings as President and CEO at Century Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 15, 2026, including sale activity and purchase activity. Recent filings connect the profile to Century Therapeutics, Inc. (IPSC) and Corbus Pharmaceuticals Holdings, Inc. (CRBP). The current snapshot covers public activity from Dec 6, 2024 to Jun 15, 2026. Reported amounts are shown as $31.0K to $27.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $27k34.7k shares | SellFeb 18, 2025 | $0.783 | $2.19 | |
| $1.4k2.2k shares | SellMar 10, 2025 | $0.615 | $2.19 | |
| $16k29.6k shares | SellMay 16, 2025 | $0.546 | $2.19 | |
| $295475 shares | SellJun 9, 2025 | $0.622 | $2.19 | |
| $244488 shares | SellSep 8, 2025 | $0.50 | $2.19 | |
| $15k32.5k shares | SellNov 17, 2025 | $0.454 | $2.19 | |
| $17k35k shares | BuyNov 19, 2025 | $0.4951 | $2.19 |